tripeptide analogTherapeutic Peptides
Trofinetide (Daybue)
A synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1). First FDA-approved treatment for Rett syndrome (March 2023). One of the shortest FDA-approved peptide drugs at only three amino acids.
rett-syndromeneuroprotectiveanti-inflammatoryFDA-approved
3D Structure
3D Structure
263.29 Da
43 atoms
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
ESI-MS (computed)
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1). First FDA-approved treatment for Rett syndrome (March 2023). One of the shortest FDA-approved peptide drugs…